German

Generated Narrative: MedicationRequest mii-exa-onko-modification-oxaliplatin-request

Profile: MII PR Onkologie Therapieempfehlung Medikation version: 2027.0.0-ballot.1

status: Stopped

statusReason: Oxaliplatin discontinued after cycle 6 due to grade 3 peripheral neuropathy (CTCAE). Patient continued with 5-FU + Leucovorin only for remaining 6 cycles.

intent: Proposal

medication: Oxaliplatin

subject: Martin Beispiel Male, DoB: 1958-11-03

authoredOn: 2024-03-05

reasonReference: Condition Bösartige Neubildung: Colon ascendens

note:

Administered for cycles 1-6 only. Stopped due to cumulative neurotoxicity.